Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
66,716,414
-
Shares change
-
+1,409,413
-
Total reported value, excl. options
-
$6,891,080,476
-
Value change
-
+$149,538,106
-
Put/Call ratio
-
8.9%
-
Number of buys
-
95
-
Number of sells
-
69
-
Price
-
$103.26
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q3 2022
As of 30 Sep 2022 Ascendis Pharma A/S - ADR (ASND) had 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 66,716,414 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Artisan Partners Limited Partnership, FMR LLC, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, WESTFIELD CAPITAL MANAGEMENT CO LP, GOLDMAN SACHS GROUP INC, and Avoro Capital Advisors LLC.
This table shows 177 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.